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Recent Developments in Surgery
Minimally Invasive Approaches for Patients
Requiring Pancreaticoduodenectomy
Scott A. Zenoni, MD; J. Pablo Arnoletti, MD; Sebastian G. de la Fuente, MD

Over the past decade, minimally invasive surgery has been introduced as a means to allow
manipulation of delicate tissues with outstanding visualization of the surgical field. The
purpose of this article is to review the available literature regarding early postoperative
outcomes and the technical challenges of minimally invasive pancreaticoduodenectomy,
including robotic techniques. Herein, we provide a retrospective review of all published
studies in the English literature in which a minimally invasive pancreaticoduodenectomy
was performed. The reported advantages of minimally invasive pancreaticoduodenectomy
include better visualization, faster recovery time, and decreased length of hospital stay. In
cases of robotic approaches, some of the proposed advantages include increased dexterity
and a superior ergonomic position for the operating surgeon. To our knowledge, few studies
have reported results comparable to open techniques in oncologic outcomes with regard to
the number of lymph nodes resected and clear margins obtained. An increasing number of
pancreatic resections are being performed using minimally invasive approaches. It remains to
be determined if the benefits of this technique outweigh its longer operative times and
higher costs.
JAMA Surg. 2013;148(12):1154-1157. doi:10.1001/jamasurg.2013.366
Published online October 23, 2013.

A

pancreaticoduodenectomy (PD) has been universally
accepted as the only chance for cure for patients
with cancerous tumors on the head of the pancreas,
distal common bile duct tumors, and periampullary
malignant tumors. Since first described by Alessandro
Codivilla in 18981 and later popularized by Whipple et al2
in 1935, significant improvements have been achieved in
the preoperative, intraoperative, and postoperative management of patients with pancreatic cancers, resulting in
decreased morbidity and mortality rates when surgical
procedures are performed at high-volume institutions. 3
These advances have allowed surgeons to explore less
invasive alternative techniques with the intention of obtaining faster recovery times while maintaining sound oncologic
outcomes.4-6 Over the last several years, the introduction
of minimally invasive techniques and robotic systems to
the field of surgical oncology has allowed for improved
visualization of the surgical field with precise manipulation
of delicate tissues. For patients with pancreatic cancer,
this is of paramount importance because an increasing
number of patients undergo neoadjuvant therapy prior
to surgical resection, which makes the distinction of normal
dissection planes challenging. To date, only a handful
of institutions have retrospectively reported their experience with laparoscopic and robotic PD (Table), with conflicting results. With this background, the purpose of our
1154
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study is to review the current data available on minimally
invasive PD.

First Reports of Laparoscopic PD
Laparoscopic PD was first reported in 1994 by Gagner and
Pomp4 in a young patient with chronic pancreatitis from pancreas divisum. Since then, a growing number of surgeons have
published their early experience with these procedures.5,6,11-13
These early studies mainly focused on the feasibility of the
technique and on early postoperative outcomes. In general,
early data show outcomes similar to those with open techniques, with faster recovery times as evidenced by shorter intensive care unit and overall hospital stays. A recent review by
Gumbs et al14 published in 2011 found 27 articles comprising
285 cases of laparoscopic PD, including 13% of hand-assisted
cases. In this extensive review,14 the rate of conversion to an
open approach was 9%, with a weighted average length of stay
of 12 days and a morbidity rate of 48%. Based on these findings, Gumbs et al14 concluded that laparoscopic pancreatic head
resections are not only feasible but also safe, with low mortality rates and acceptable complication rates. The authors further emphasized the lack of long-term follow-up data and the
relatively small number of studies comparing minimally invasive techniques with open techniques.14
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Table. Current Studies Available on Robotic-Assisted Pancreaticoduodenectomy
Median (Range) or Mean (SD)
Source, y

Patients, Operative
No. Times, min

Estimated
Blood Loss, mL

Length
of Stay, d

Pathology
Data

Leak
Rate,
%

Complication
Rate, %

Giulianotti
et al,7 2001a

50

421 (240-660)

394 (80-1500)

22 (5-85)

Positive margin rate of
0% in Italy and 21% in
US; 21 and 15 mean
lymph nodes
harvested in Italy and
US, respectively

31.3

Did not discriminate
among complications
based on surgical
approach

Zureikat
et al,5 2011

30

512 (327-848)

320 (50-1000)

9 (4-87)

Not available

27

27 (Clavien grade I and
grade II), 23 (Clavien
grade III and grade IV)

Zhou et al,8
2011

8

718 (186)

153 (43)

16.4 (4.1)

R0 resection rate of
100%

50

25

Chalikonda
et al,9 2012

30

476 (363-727)

485 (50-3500)

9.79

Mean tumor diameter
of 2.9 cm

13

30

Buchs et al,10
2010b

42

Older, 420 (62);
younger, 443.8 (9)

Older, 388 (282);
younger, 390 (379)

Older, 14.3 (8.3);
younger, 11.2 (4.8)

Not available

19.5

39

a

Patients were from Italy and the United States (US).

b

Comparing 2 groups of patients undergoing robotic-assisted pancreaticoduodenectomy (patients <70 years vs patients ⱖ70 years).

Comparison of Techniques:
Laparoscopic vs Open PD

Box. Proposed Advantages of 2 Different Types
of Pancreaticoduodenectomy (PD)

With the increasing number of surgeons rapidly gaining
experience in complex laparoscopic pancreatic techniques,
the first reports of comparative studies have recently been
published.9,11,15 In a retrospective review of 51 consecutive
patients who underwent either an open or a laparoscopic
PD, Kuroki and colleagues15 found decreased blood loss in
the laparoscopy-assisted PD group compared with the open
PD group. Furthermore, these investigators found no significant differences in the occurrence of postoperative complications between the 2 groups. 15 To our knowledge,
Asburn and Stauffer11 recently published the largest comparative study of more than 260 patients, 53 of whom
underwent a laparoscopic PD. Intraoperative and postoperative factors in favor of a laparoscopic approach included
decreased blood loss, shorter lengths of hospital stay and
intensive care unit stay, transfusion requirements, and
greater number of lymph nodes retrieved at the time of the
operation. Importantly, no differences were noted in the
rate of early postoperative morbidity or mortality. As
expected, operative times were significantly longer for laparoscopic cases, with a mean (SD) time per case of 541 (88)
minutes (9 hours).

Advantages of Minimally Invasive PD

Theoretical Advantages of Robotic-Assisted PD
It is generally accepted that the use of robotic systems provides improved visualization with 3-dimensional imaging
and improved movement of instrumentation in limited
spaces and ensures better ergonomics for the operating
surgeon16 (Box). These observations arose from a series of
retrospective studies describing the first experiences using
robotics for PD. Giulianotti and colleagues7 reported in 2010
the first series of 50 patients who underwent roboticjamasurgery.com

Decreased blood loss, resulting in less transfusions
Shorter hospital stays
Shorter intensive care unit stays
Superior cosmetics
Advantages of Robotic-Assisted PD

Improved 3-dimensional imaging
Enhanced dexterity
Better visualization, increased magnification
Improved ergonomics

assisted PD in Italy and the United States. In this retrospective study, the median operative time was 421 minutes
(range, 240-660 minutes), with a median blood loss of 394
cm3 (range, 80-1500 cm3). The length of stay significantly
varied depending on the location. In the Italian group, the
mean length of stay was 28.7 days, whereas in the US group,
the mean length of stay was 12.5 days. In this series, 7
6 patients had a grade A fistula postoperatively, 5 patients
had a grade B fistula postoperatively, and 1 patient had a
grade C fistula postoperatively. More recently, in a singleinstitution retrospective review, Zureikat and colleagues17
reported on 24 patients who underwent a robotic-assisted
nonpylorus-preserving PD at the University of Pittsburgh in
Pennsylvania. The median operative time in this study17
was 512 minutes (range, 327-848 minutes), with a median
blood loss of 320 cm3 (range, 50-1000 cm3) and a median
length of stay of 9 days (range, 4-87 days). The overall pancreatic fistula rate was 27% (n = 8). Clavien grade III and
grade IV complications occurred in 7 patients (23%),
whereas Clavien grade I and grade II complications occurred
in 27% of patients.
JAMA Surgery December 2013 Volume 148, Number 12
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Other investigators have compared robotic-assisted PD
with open PD. Zhou et al8 reported on 16 patients who had
no significant difference in negative margin rates but had
lower rates of blood loss, lower complications rates, and
decreased lengths of stay with robotic-assisted PD. The low
number of patients in this study8 prohibits any meaningful
statistical analysis. A larger study by Chalikonda and
colleagues 9 compared 30 patients undergoing roboticassisted PD with 30 patients undergoing open PD; both
groups had similar demographic characteristics and surgical
indications. Operative times were significantly longer in the
robotic-assisted group, but their overall blood loss was
lower. The mean lengths of stay were significantly different
between groups (9.79 days for the robotic-assisted group vs
13.26 days for the open group; P = .04). Based on these limited data, both studies8,9 concluded that robotic-assisted PD
might be associated with faster recovery times but longer
operative times.
With regard to immediate oncologic outcomes, Zeh et
al18 reported on 50 consecutives patients who underwent a
robotic-assisted PD (36 underwent a classic PD, and 14
underwent a pylorus-preserving PD). The median tumor
size was 2.5 cm, with a mean (SD) of 17 (7) lymph nodes
retrieved. For these patients, the overall margin-negative
(R0) resection rate was 89%. Importantly, 11 of the
15 patients who met the criteria for adjuvant therapy
were treated at a mean follow-up of 11.5 weeks postoperatively.

Current Limitations
The main limitations of robotic procedures are related to the
high costs associated with the purchase of the robotic system and disposable equipment 19 and the steep learning
curve associated with the technique. To date, studies comparing the cost-effectiveness of robotic-assisted PD or minimally invasive PD with the cost-effectiveness of open PD
have not been conducted.
As with other complex operations, there is a lack of
data regarding the recommended number of procedures a

Conclusions
Minimally invasive techniques provide some benefits to
patients requiring a PD. The robotic systems currently available are not hindered by some of the limitations that plague
laparoscopic techniques, such as a limited range of motion,
a 2-dimensional visualization of the surgical field, and poor
ergonomics for surgeons. For example, the ability of the
system to compensate for natural tremors may allow for a
more precise technique when a delicate anastomosis
is constructed. 10 However, it is intriguing that the available data on minimally invasive techniques have failed
to demonstrate improvements in outcomes, such as leak
rates and conversion rates, compared with the outcomes
associated with laparoscopic techniques. The need for a longer learning curve might serve to explain some of these
issues.
Currently, data on oncologic outcomes have been limited to a few retrospective reports, and there is a lack of literature investigating the financial implications of this
approach. The need for cost-effective approaches that could
potentially provide similar or better early and late results is
essential in times of financial difficulties. Although shorter
hospital stays are certainly appealing, based on currently
available data, the faster recovery times associated with
minimally invasive approaches have not resulted in adjuvant chemotherapy being initiated sooner. From the perspective of general surgery residents, it is imperative to
understand that only after rigorous unbiased examination
could minimally invasive PD potentially become a valid tool
in the armamentarium of surgeons for treating pancreatic
cancer.
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